The concentration of the health care distribution industry provides Cardinal Health and AmerisourceBergen with competitive advantages and high barriers to entry. This provides Cardinal Health and ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health is a leader in its industry and has had another stellar quarterly performance with revenues increasing 13%. A part of a growing industry, the company has both a strong financial ground ...

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 ...

U.S. Rep. Veronica Escobar, D-El Paso, issued a letter to the CEO of Cardinal Health, Jason Hollar, after an investigation ...

With the onset of the Covid-19 pandemic, Cardinal Health made the decision they needed enhanced visibility into PPE shipments as demand for these products surged. Since then, FourKites has become a ...

Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 ...

Cardinal Health, Inc. corporate office in Dublin, Ohio. As Cardinal Health continues its digital transformation efforts, newly appointed Chief Information Officer Michelle Greene is focused on ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Cardinal Health Inc. CAH on Thursday said it authorized a new $3.5 billion stock buyback program until the end of 2027. Cardinal Health said it expects 2024 adjusted profit of $6.45 to $6.70 a share, ...

Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...